What made Corvus stock double on Tuesday and is it sustainable?
Corvus Pharmaceuticals(US:CRVS) Invezz·2026-01-21 03:10Corvus Pharmaceuticals (NASDAQ: CRVS) shares more than doubled on Jan. 20 after announcing positive Phase 1 trial data for "soquelitinib†– its oral investigational drug for atopic dermatitis. Soqueli... ...